Newsletter Subject

Paxlovid and COVID; Breast Cancer and Lymph Node Removal

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Apr 27, 2024 11:15 AM

Email Preheader Text

Weekly Review Saturday, April 27, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CME

[MEDPAGE TODAY]( Weekly Review Saturday, April 27, 2024 [Paxlovid and COVID; Breast Cancer and Lymph Node Removal]( [Doctors Sue Google Over Bad Reviews; $425K Stolen From UPMC? Doc's Alleged Sex Crime]( [High BMI and Longevity; Infective Endocarditis in Young Whites; Damar Hamlin Update]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Improving Real-World Care For Veteran Patients With Hepatocellular Carcinoma: Strategies for Patient-Centered, Teams-Based Approaches]( [Is There a Vaccine for H5N1 Influenza?]( [COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Sexual Orientation Among Female Nurses Tied to Premature Death]( CME SPOTLIGHT [The Future of NSCLC Care: Leveraging Biomarker Testing in the Management of Early-Stage, Resectable Disease]( [Hands-On Treatment May Help in Knee Osteoarthritis]( [Long COVID Taste Loss May Not Involve Taste Buds]( [Herpes B: A Hidden Menace in Monkeys]( CME SPOTLIGHT [Moving the Needle: Adopting New Evidence Into the Lower-Risk Myelodysplastic Syndrome Treatment Paradigm]( [Taylor Swift's Ode to Medicine? Luxury Scrubs Gone Too Far; RN vs MD Salaries]( [When Neglect Becomes Criminal: The Harsh Reality of Failing a Dependent]( [Houston Transplant Scandal: Families of Patients Who Died Begin Legal Action]( CME SPOTLIGHT [Optimizing the Management of Patients With mCRPC in Rural Communities: A Project ECHO Initiative]( [FDA Approves New Option for Uncomplicated UTIs in Women]( [Burnout Is Not Going Away. Here Are Three 'Microskills' to Mitigate It.]( [California Nurses Rally Against AI Tools in Healthcare]( CME SPOTLIGHT [Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer]( [COVID Shot Boosts Mucosal Immunity in Previously Infected People]( [Ex-Con Charged With Murdering Home Care Nurse]( [Supreme Court Justices Appear Divided on EMTALA Case]( CME SPOTLIGHT [Novel and Emerging Evidence in Early-Stage Breast Cancer]( ['Is This Like a 'Don't Ask, Don't Tell' Policy?': What We Heard This Week]( [Ozempic Hiatus Before Surgery: Is a Weeklong Pause Really Needed?]( [Men Too: Sexual Harassment in the Operating Room]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [New T2D Guidelines; More Cushing's Relacorilant Data; Drug Shortages Rage On]( [FDA Announces Recall of Heart Pumps Linked to Deaths and Injuries]( [Clue to Aspirin, Colon Cancer Link; New Lutathera Approval; AI & Electronic Records]( CME SPOTLIGHT [Employing Collaborative Care Strategies for the Management of Pediatric Patients With Hodgkin Lymphoma]( [The Real Forces That Motivate Us in Healthcare]( [Want to Be a Better Psychiatrist? Enter a Beauty Pageant!]( [CVS Pharmacy Location Becomes the First to Join New National Union]( [Dementia May Be Underdiagnosed in States With Motor Vehicle Reporting Mandates]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-04-27&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

06/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.